{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:05:04Z","timestamp":1789625104021,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Glioblastoma is an aggressive primary brain tumor with a poor prognosis despite multimodal treatment. Geographic residence may influence access to medical care and, consequently, both treatment utilization and survival; however, the impact of urban\u2013rural residence on these outcomes in patients with glioblastoma remains underexplored. Identifying these disparities can help inform targeted strategies to improve outcomes. Patients diagnosed with primary glioblastoma were identified from the Surveillance, Epidemiology, and End Results database. Multivariable logistic regression was used to evaluate the association between residence and the receipt of definitive treatments. Propensity score matching was performed to balance baseline characteristics, and Kaplan\u2013Meier curves were used to estimate cancer-specific survival (CSS). An independent cohort from West China Hospital was additionally included for external validation, with analyses primarily focusing on survival outcomes. A total of 10,041 glioblastoma patients were included. Compared to urban patients, rural patients were less likely to receive local surgery (odds ratio [OR]\u2005=\u20050.84, 95% confidence interval [CI]\u2005=\u20050.72\u20130.96,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.009), radiotherapy (OR\u2005=\u20050.84, 95% CI\u2005=\u20050.72\u20130.97,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.012), and chemotherapy (OR\u2005=\u20050.89, 95% CI\u2005=\u20050.80\u20130.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.046). Post-propensity score matching analysis showed that rural patients had worse CSS compared to urban patients (hazard ratio [HR]\u2005=\u20051.12, 95% CI\u2005=\u20051.05\u20131.20,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Subgroup analysis by diagnosis year revealed a narrowing urban\u2013rural disparity over time (2000\u20132009, HR\u2005=\u20051.15, 95% CI\u2005=\u20051.06\u20131.25,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001; 2010\u20132019, HR\u2005=\u20051.10, 95% CI\u2005=\u20051.01\u20131.20,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.046). Further subgroup analysis indicated that this disparity was consistent regardless of income (median household income\u2005&lt;\u200575,000 United States dollars, HR\u2005=\u20051.11, 95% CI\u2005=\u20051.04\u20131.19,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.001; &gt;75,000 United States dollars, HR\u2005=\u20051.08, 95% CI\u2005=\u20051.02\u20131.20,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.036). External validation showed a trend toward worse CSS among rural patients, but the difference was not statistically significant (HR\u2005=\u20051.33, 95% CI\u2005=\u20050.96\u20131.84,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.085). Overall, rural residence was associated with lower utilization of treatments and worse CSS among patients with glioblastoma. These findings highlight the need for targeted strategies to improve healthcare access and reduce urban\u2013rural disparities in clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050325","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:05:39Z","timestamp":1787331939000},"page":"e50325","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of urban\u2013rural residence on treatment and survival in patients with glioblastoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Changping","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chengdu Second People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1241-6059","authenticated-orcid":false,"given":"Chenbo","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Orthopedic, The Affiliated Chengdu 363 Hospital of Southwest Medical University, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1148\/rg.210236","article-title":"Major Changes in 2021 World Health Organization Classification of Central Nervous System tumors.","volume":"42","author":"Kurokawa","year":"2022","journal-title":"Radiographics"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S1470-2045(17)30194-8","article-title":"European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejca.2014.12.014","article-title":"Glioblastoma in England: 2007-2011.","volume":"51","author":"Brodbelt","year":"2015","journal-title":"Eur J Cancer"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3390\/cancers14133161","article-title":"Survival outcomes and prognostic factors in glioblastoma.","volume":"14","author":"Brown","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"9993","DOI":"10.1038\/s41467-024-54444-2","article-title":"An umbrella review of socioeconomic status and cancer.","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/cncr.32073","article-title":"Rural-urban residence and cancer survival in high-income countries: a systematic review.","volume":"125","author":"Afshar","year":"2019","journal-title":"Cancer"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"e0228551","DOI":"10.1371\/journal.pone.0228551","article-title":"Differences in cancer survival by area-level socio-economic disadvantage: a population-based study using cancer registry data.","volume":"15","author":"Afshar","year":"2020","journal-title":"PLoS One"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/cam4.1382","article-title":"Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah.","volume":"7","author":"Hashibe","year":"2018","journal-title":"Cancer Med"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","article-title":"Distance as a barrier to cancer diagnosis and treatment: review of the literature.","volume":"20","author":"Ambroggi","year":"2015","journal-title":"Oncologist"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/1475-6773.13951","article-title":"Definition and categorization of rural and assessment of realized access to care.","volume":"57","author":"Zahnd","year":"2022","journal-title":"Health Serv Res"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnci\/djad031","article-title":"Defining rurality: an evaluation of rural definitions and the impact on survival estimates.","volume":"115","author":"Franks","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.lungcan.2014.01.008","article-title":"Treatment and survival disparities in lung cancer: the effect of social environment and place of residence.","volume":"83","author":"Johnson","year":"2014","journal-title":"Lung Cancer"},{"key":"R18-20260917","first-page":"358","article-title":"Regional disparities in treatment and survival of early stage non-small cell lung cancer.","volume":"17","author":"Crowell","year":"2007","journal-title":"Ethn Dis"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/ajr.12172","article-title":"Survival from breast, colon, lung, ovarian and rectal cancer by geographical remoteness in New South Wales, Australia, 2000-2008.","volume":"23","author":"Chen","year":"2015","journal-title":"Aust J Rural Health"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.breast.2015.03.006","article-title":"Temporal trends show improved breast cancer survival in Australia but widening urban-rural differences.","volume":"24","author":"Yu","year":"2015","journal-title":"Breast"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/1471-2407-13-493","article-title":"Geographic remoteness, area-level socioeconomic disadvantage and inequalities in colorectal cancer survival in Queensland: a multilevel analysis.","volume":"13","author":"Baade","year":"2013","journal-title":"BMC Cancer"},{"key":"R22-20260917","first-page":"2668","article-title":"Colorectal cancer outcome inequalities: association between population density, race, and socioeconomic status.","volume":"14","author":"Fitzgerald","year":"2014","journal-title":"Rural Remote Health"},{"key":"R23-20260917","first-page":"2039","article-title":"Prostate cancer incidence and mortality in rural men--a systematic review of the literature.","volume":"12","author":"Obertova","year":"2012","journal-title":"Rural Remote Health"},{"key":"R24-20260917","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s12032-011-0077-8","article-title":"Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.","volume":"29","author":"Martinez","year":"2012","journal-title":"Med Oncol"},{"key":"R25-20260917","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00008469-200502000-00002","article-title":"Weak associations between sociodemographic factors and breast cancer: possible effects of early detection.","volume":"14","author":"Robsahm","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"R26-20260917","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12913-016-1263-3","article-title":"Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study.","volume":"16","author":"Beckmann","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"R27-20260917","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1748-0361.2005.tb00089.x","article-title":"Urban, rural, and regional variations in physical activity.","volume":"21","author":"Martin","year":"2005","journal-title":"J Rural Health"},{"key":"R28-20260917","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.3402\/fnr.v55i0.5819","article-title":"Less-healthy eating behaviors have a greater association with a high level of sugar-sweetened beverage consumption among rural adults than among urban adults.","volume":"55","author":"Sharkey","year":"2011","journal-title":"Food Nutr Res"},{"key":"R29-20260917","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial.","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"R30-20260917","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"R31-20260917","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma.","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"R32-20260917","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.pec.2011.01.036","article-title":"Rural-urban differences in discussions of cancer treatment clinical trials.","volume":"85","author":"Vanderpool","year":"2011","journal-title":"Patient Educ Couns"},{"key":"R33-20260917","doi-asserted-by":"crossref","first-page":"e181235","DOI":"10.1001\/jamanetworkopen.2018.1235","article-title":"Geographic distribution and survival outcomes for rural patients with cancer treated in clinical trials.","volume":"1","author":"Unger","year":"2018","journal-title":"JAMA Netw Open"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:01:14Z","timestamp":1789624874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050325"}},"subtitle":["A SEER-based study with external validation"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":30,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050325","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2026-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}